Predictors of sudden onset of sleep in Parkinson's disease
Identifieur interne : 003A79 ( Main/Exploration ); précédent : 003A78; suivant : 003A80Predictors of sudden onset of sleep in Parkinson's disease
Auteurs : Yvonne Körner [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Jens Carsten Möller [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Doris Haja [Allemagne] ; Werner Cassel [Allemagne] ; Wolfgang Hermann Oertel [Allemagne] ; Hans-Peter Krüger [Allemagne]Source :
- [ 0885-3185 ]
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Benzothiazoles, Comorbidity, Cross-Sectional Studies, Dopamine Agonists (adverse effects), Dopamine Agonists (therapeutic use), Drug Therapy, Combination, Ergolines (adverse effects), Ergolines (therapeutic use), Female, Humans, Indoles (adverse effects), Indoles (therapeutic use), Levodopa (adverse effects), Levodopa (therapeutic use), Male, Middle Aged, Narcolepsy (diagnosis), Narcolepsy (etiology), Nervous system diseases, Parkinson Disease (complications), Parkinson Disease (drug therapy), Parkinson Disease (epidemiology), Parkinson disease, Questionnaires, Risk Factors, Sleep, Sudden, Thiazoles (adverse effects), Thiazoles (therapeutic use).
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Dopamine Agonists, Ergolines, Indoles, Levodopa, Thiazoles.
- chemical , therapeutic use : Antiparkinson Agents, Dopamine Agonists, Ergolines, Indoles, Levodopa, Thiazoles.
- complications : Parkinson Disease.
- diagnosis : Narcolepsy.
- drug therapy : Parkinson Disease.
- epidemiology : Parkinson Disease.
- etiology : Narcolepsy.
- Aged, Benzothiazoles, Comorbidity, Cross-Sectional Studies, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Questionnaires, Risk Factors.
Abstract
With respect to the ongoing discussion of “sleep attacks” in Parkinson's disease (PD), we sought to estimate the prevalence of sudden onset of sleep (SOS) with and without preceding sleepiness in PD, to identify associated factors, and to define the role of antiparkinsonian medication in SOS. We sent a questionnaire about SOS, sleep behaviour, and medication to 12,000 PD patients. The response rate was 63%, from which 6,620 complete data sets could be analysed. A total of 42.9% of our population reported SOS, 10% of whom never experienced sleepiness before the appearance of SOS (4.3% of all), and we identified the administration of all dopaminergic drugs as a risk factor for SOS. However, SOS occurred earlier after introduction of nonergoline dopamine agonists (DA) and was more strongly associated with nonergoline DA in younger patients (below 70 years) with a shorter disease duration (up to 7 years) but, actually, medication was less efficient in predicting SOS than most other factors considered such as higher age, male sex, longer disease duration, and the report of sleep disturbances. This survey strongly suggests that SOS is a multifactorial phenomenon. Some subgroups are at particular risk of experiencing SOS under nonergoline DA, especially at the beginning of this therapy. Our results support the current notion that SOS, in part, can be attributed to PD‐specific pathology because disease duration and subjective disease severity have been shown to be predictors of SOS. We recommend the development of a standardised question to recognise SOS and to facilitate the comparison of prevalence estimates. © 2004 Movement Disorder Society
DOI: 10.1002/mds.20163
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003587
- to stream Istex, to step Curation: 003587
- to stream Istex, to step Checkpoint: 002460
- to stream PubMed, to step Corpus: 003306
- to stream PubMed, to step Curation: 003306
- to stream PubMed, to step Checkpoint: 003362
- to stream Ncbi, to step Merge: 000F82
- to stream Ncbi, to step Curation: 000F82
- to stream Ncbi, to step Checkpoint: 000F82
- to stream Main, to step Merge: 005437
- to stream PascalFrancis, to step Corpus: 002014
- to stream PascalFrancis, to step Curation: 000D07
- to stream PascalFrancis, to step Checkpoint: 002049
- to stream Main, to step Merge: 005887
- to stream Main, to step Curation: 003A79
Le document en format XML
<record><TEI wicri:istexFullTextTei="no"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Predictors of sudden onset of sleep in Parkinson's disease</title><author><name sortKey="Korner, Yvonne" sort="Korner, Yvonne" uniqKey="Korner Y" first="Yvonne" last="Körner">Yvonne Körner</name></author><author><name sortKey="Meindorfner, Charlotte" sort="Meindorfner, Charlotte" uniqKey="Meindorfner C" first="Charlotte" last="Meindorfner">Charlotte Meindorfner</name></author><author><name sortKey="Moller, Jens Carsten" sort="Moller, Jens Carsten" uniqKey="Moller J" first="Jens Carsten" last="Möller">Jens Carsten Möller</name></author><author><name sortKey="Stiasny Olster, Karin" sort="Stiasny Olster, Karin" uniqKey="Stiasny Olster K" first="Karin" last="Stiasny-Kolster">Karin Stiasny-Kolster</name></author><author><name sortKey="Haja, Doris" sort="Haja, Doris" uniqKey="Haja D" first="Doris" last="Haja">Doris Haja</name></author><author><name sortKey="Cassel, Werner" sort="Cassel, Werner" uniqKey="Cassel W" first="Werner" last="Cassel">Werner Cassel</name></author><author><name sortKey="Oertel, Wolfgang Hermann" sort="Oertel, Wolfgang Hermann" uniqKey="Oertel W" first="Wolfgang Hermann" last="Oertel">Wolfgang Hermann Oertel</name></author><author><name sortKey="Kruger, Hans Eter" sort="Kruger, Hans Eter" uniqKey="Kruger H" first="Hans-Peter" last="Krüger">Hans-Peter Krüger</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A08161CA038D78957D5107F534BA1074B39F4ADD</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1002/mds.20163</idno><idno type="wicri:Area/Istex/Corpus">003587</idno><idno type="wicri:Area/Istex/Curation">003587</idno><idno type="wicri:Area/Istex/Checkpoint">002460</idno><idno type="wicri:doubleKey">0885-3185:2004:Korner Y:predictors:of:sudden</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:15389999</idno><idno type="wicri:Area/PubMed/Corpus">003306</idno><idno type="wicri:Area/PubMed/Curation">003306</idno><idno type="wicri:Area/PubMed/Checkpoint">003362</idno><idno type="wicri:Area/Ncbi/Merge">000F82</idno><idno type="wicri:Area/Ncbi/Curation">000F82</idno><idno type="wicri:Area/Ncbi/Checkpoint">000F82</idno><idno type="wicri:doubleKey">0885-3185:2004:Korner Y:predictors:of:sudden</idno><idno type="wicri:Area/Main/Merge">005437</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:05-0001411</idno><idno type="wicri:Area/PascalFrancis/Corpus">002014</idno><idno type="wicri:Area/PascalFrancis/Curation">000D07</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002049</idno><idno type="wicri:doubleKey">0885-3185:2004:Korner Y:predictors:of:sudden</idno><idno type="wicri:Area/Main/Merge">005887</idno><idno type="wicri:Area/Main/Curation">003A79</idno><idno type="wicri:Area/Main/Exploration">003A79</idno></publicationStmt><sourceDesc><biblStruct><analytic><author><name sortKey="Korner, Yvonne" sort="Korner, Yvonne" uniqKey="Korner Y" first="Yvonne" last="Körner">Yvonne Körner</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Center for Traffic Sciences, Department of Psychology, University of Wuerzburg, Wuerzburg</wicri:regionArea><wicri:noRegion>Wuerzburg</wicri:noRegion><wicri:noRegion>Wuerzburg</wicri:noRegion></affiliation></author><author><name sortKey="Meindorfner, Charlotte" sort="Meindorfner, Charlotte" uniqKey="Meindorfner C" first="Charlotte" last="Meindorfner">Charlotte Meindorfner</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Center for Traffic Sciences, Department of Psychology, University of Wuerzburg, Wuerzburg</wicri:regionArea><wicri:noRegion>Wuerzburg</wicri:noRegion><wicri:noRegion>Wuerzburg</wicri:noRegion></affiliation></author><author><name sortKey="Moller, Jens Carsten" sort="Moller, Jens Carsten" uniqKey="Moller J" first="Jens Carsten" last="Möller">Jens Carsten Möller</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Philipps‐University Marburg, Marburg</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Giessen</region><settlement type="city">Marbourg</settlement></placeName></affiliation></author><author><name sortKey="Stiasny Olster, Karin" sort="Stiasny Olster, Karin" uniqKey="Stiasny Olster K" first="Karin" last="Stiasny-Kolster">Karin Stiasny-Kolster</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Philipps‐University Marburg, Marburg</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Giessen</region><settlement type="city">Marbourg</settlement></placeName></affiliation></author><author><name sortKey="Haja, Doris" sort="Haja, Doris" uniqKey="Haja D" first="Doris" last="Haja">Doris Haja</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Center for Traffic Sciences, Department of Psychology, University of Wuerzburg, Wuerzburg</wicri:regionArea><wicri:noRegion>Wuerzburg</wicri:noRegion><wicri:noRegion>Wuerzburg</wicri:noRegion></affiliation></author><author><name sortKey="Cassel, Werner" sort="Cassel, Werner" uniqKey="Cassel W" first="Werner" last="Cassel">Werner Cassel</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Internal Medicine, Philipps‐University Marburg, Marburg</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Giessen</region><settlement type="city">Marbourg</settlement></placeName></affiliation></author><author><name sortKey="Oertel, Wolfgang Hermann" sort="Oertel, Wolfgang Hermann" uniqKey="Oertel W" first="Wolfgang Hermann" last="Oertel">Wolfgang Hermann Oertel</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Philipps‐University Marburg, Marburg</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Giessen</region><settlement type="city">Marbourg</settlement></placeName></affiliation></author><author><name sortKey="Kruger, Hans Eter" sort="Kruger, Hans Eter" uniqKey="Kruger H" first="Hans-Peter" last="Krüger">Hans-Peter Krüger</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Center for Traffic Sciences, Department of Psychology, University of Wuerzburg, Wuerzburg</wicri:regionArea><wicri:noRegion>Wuerzburg</wicri:noRegion><wicri:noRegion>Wuerzburg</wicri:noRegion></affiliation></author></analytic><series><idno type="ISSN">0885-3185</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Benzothiazoles</term><term>Comorbidity</term><term>Cross-Sectional Studies</term><term>Dopamine Agonists (adverse effects)</term><term>Dopamine Agonists (therapeutic use)</term><term>Drug Therapy, Combination</term><term>Ergolines (adverse effects)</term><term>Ergolines (therapeutic use)</term><term>Female</term><term>Humans</term><term>Indoles (adverse effects)</term><term>Indoles (therapeutic use)</term><term>Levodopa (adverse effects)</term><term>Levodopa (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Narcolepsy (diagnosis)</term><term>Narcolepsy (etiology)</term><term>Nervous system diseases</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (epidemiology)</term><term>Parkinson disease</term><term>Questionnaires</term><term>Risk Factors</term><term>Sleep</term><term>Sudden</term><term>Thiazoles (adverse effects)</term><term>Thiazoles (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term><term>Dopamine Agonists</term><term>Ergolines</term><term>Indoles</term><term>Levodopa</term><term>Thiazoles</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Dopamine Agonists</term><term>Ergolines</term><term>Indoles</term><term>Levodopa</term><term>Thiazoles</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Narcolepsy</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Narcolepsy</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Benzothiazoles</term><term>Comorbidity</term><term>Cross-Sectional Studies</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Questionnaires</term><term>Risk Factors</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Brutal</term><term>Parkinson maladie</term><term>Sommeil</term><term>Système nerveux pathologie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">With respect to the ongoing discussion of “sleep attacks” in Parkinson's disease (PD), we sought to estimate the prevalence of sudden onset of sleep (SOS) with and without preceding sleepiness in PD, to identify associated factors, and to define the role of antiparkinsonian medication in SOS. We sent a questionnaire about SOS, sleep behaviour, and medication to 12,000 PD patients. The response rate was 63%, from which 6,620 complete data sets could be analysed. A total of 42.9% of our population reported SOS, 10% of whom never experienced sleepiness before the appearance of SOS (4.3% of all), and we identified the administration of all dopaminergic drugs as a risk factor for SOS. However, SOS occurred earlier after introduction of nonergoline dopamine agonists (DA) and was more strongly associated with nonergoline DA in younger patients (below 70 years) with a shorter disease duration (up to 7 years) but, actually, medication was less efficient in predicting SOS than most other factors considered such as higher age, male sex, longer disease duration, and the report of sleep disturbances. This survey strongly suggests that SOS is a multifactorial phenomenon. Some subgroups are at particular risk of experiencing SOS under nonergoline DA, especially at the beginning of this therapy. Our results support the current notion that SOS, in part, can be attributed to PD‐specific pathology because disease duration and subjective disease severity have been shown to be predictors of SOS. We recommend the development of a standardised question to recognise SOS and to facilitate the comparison of prevalence estimates. © 2004 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Allemagne</li></country><region><li>District de Giessen</li><li>Hesse (Land)</li></region><settlement><li>Marbourg</li></settlement></list><tree><country name="Allemagne"><noRegion><name sortKey="Korner, Yvonne" sort="Korner, Yvonne" uniqKey="Korner Y" first="Yvonne" last="Körner">Yvonne Körner</name></noRegion><name sortKey="Cassel, Werner" sort="Cassel, Werner" uniqKey="Cassel W" first="Werner" last="Cassel">Werner Cassel</name><name sortKey="Haja, Doris" sort="Haja, Doris" uniqKey="Haja D" first="Doris" last="Haja">Doris Haja</name><name sortKey="Kruger, Hans Eter" sort="Kruger, Hans Eter" uniqKey="Kruger H" first="Hans-Peter" last="Krüger">Hans-Peter Krüger</name><name sortKey="Meindorfner, Charlotte" sort="Meindorfner, Charlotte" uniqKey="Meindorfner C" first="Charlotte" last="Meindorfner">Charlotte Meindorfner</name><name sortKey="Moller, Jens Carsten" sort="Moller, Jens Carsten" uniqKey="Moller J" first="Jens Carsten" last="Möller">Jens Carsten Möller</name><name sortKey="Oertel, Wolfgang Hermann" sort="Oertel, Wolfgang Hermann" uniqKey="Oertel W" first="Wolfgang Hermann" last="Oertel">Wolfgang Hermann Oertel</name><name sortKey="Stiasny Olster, Karin" sort="Stiasny Olster, Karin" uniqKey="Stiasny Olster K" first="Karin" last="Stiasny-Kolster">Karin Stiasny-Kolster</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A79 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003A79 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A08161CA038D78957D5107F534BA1074B39F4ADD
|texte= Predictors of sudden onset of sleep in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |